Zimmer Biomet Holdings (ZBH) - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98956P1021
Zimmer Biomet Holdings, Inc., and its subsidiaries work as a medical technology company across different regions worldwide. They offer a variety of orthopaedic reconstructive products for knees, hips, sports medicine, foot and ankle, and trauma. Additionally, they provide solutions for reconstructing faces, skulls, and chest bones after surgery or trauma. Their product range also includes robotic, surgical, and bone cement products.
These products are utilized in treating patients with bone, joint, or soft tissue injuries or disorders. Their customer base includes orthopaedic and neurosurgeons, hospitals, healthcare dealers, and specialists. The company was initially known as Zimmer Holdings, Inc., and later changed to Zimmer Biomet Holdings, Inc., expanding on its legacy since 1927. The company's headquarters are in Warsaw, Indiana.
For more information about Zimmer Biomet Holdings, Inc., you can visit their website at https://www.zimmerbiomet.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ZBH Stock Overview
Market Cap in USD | 26,433m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2001-07-25 |
ZBH Stock Ratings
Growth 5y | -0.36 |
Fundamental | 3.64 |
Dividend | 5.23 |
Rel. Performance vs Sector | -1.58 |
Analysts | 3.39/5 |
Fair Price Momentum | 107.51 USD |
Fair Price DCF | 153.16 USD |
ZBH Dividends
Yield 12m | 0.80% |
Yield on Cost 5y | 0.85% |
Dividends CAGR 5y | 0.61% |
Payout Consistency | 98.4% |
ZBH Growth Ratios
Growth 12m | -13.08% |
Growth Correlation 12m | -15% |
Growth Correlation 3m | 33% |
CAGR 5y | 1.05% |
Sharpe Ratio 12m | -0.86 |
Alpha vs SP500 12m | -37.77 |
Beta vs SP500 5y weekly | 1.09 |
ValueRay RSI | 14.52 |
Volatility GJR Garch 1y | 24.81% |
Price / SMA 50 | -5.38% |
Price / SMA 200 | -1.32% |
Current Volume | 1414.6k |
Average Volume 20d | 1180.2k |
External Links for ZBH Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 19, 2024, the stock is trading at USD 119.33 with a total of 1,414,603 shares traded.
Over the past week, the price has changed by -6.42%, over one month by -5.09%, over three months by -3.45% and over the past year by -10.47%.
According to ValueRays Forecast Model, ZBH Zimmer Biomet Holdings will be worth about 118.9 in April 2025. The stock is currently trading at 119.33. This means that the stock has a potential downside of -0.39%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 136.9 | 14.7% |
Analysts Target Price | 143.8 | 20.5% |
ValueRay Target Price | 118.9 | -0.39% |